Adam Fox, M.D.
Improving outcomes for patients with non-small cell lung cancer by improving utilization of biomarker testing that directs treatment decisions at the time of diagnosis, recurrence, and progression.
Research Interest
I am a pulmonologist and clinician scientist with a research focus in health services research for patients with lung cancer at the Medical University of South Carolina (MUSC). My long-term research goal is to improve care delivery for patients newly diagnosed with lung cancer, especially as it relates to precision medicine therapies. My clinical time is spent evaluating patients suspected to have lung cancer in a multi-disciplinary thoracic oncology clinic, performing bronchoscopy for diagnostic or staging purposes, and collaborating on cases through our multi-disciplinary thoracic tumor board. Biomarker testing performed on patient's lung cancer tissue continues to grow in importance in driving precision medicine treatment decisions, especially as new therapies and indications emerge for both targeted and immune therapies.